Immune response to platelet transfusions
- PMID: 40662268
- PMCID: PMC12266639
- DOI: 10.1097/MOH.0000000000000888
Immune response to platelet transfusions
Abstract
Purpose of review: Platelet transfusion can have a significant immunological impact, exposing the recipient to alloantigens on the surface of platelets and contaminating leukocytes, a dynamic range of soluble immune mediators, and donor platelets that can directly and indirectly contribute to the inflammatory profile of the recipient. Here, we will review recent developments in our understanding of the mechanisms regulating the immune response to platelet transfusion.
Recent findings: Using animal models, much has been learned about the mechanisms regulating the alloimmune response to platelet transfusion and how this response is shaped by the underlying health of the recipient. There is also a growing appreciation of the active role platelets play in immunity and their impact on the recipient immune system and transfusion outcomes, and how these immunological profiles are shaped by product collection, processing, and storage practices.
Summary: While platelet transfusion carries significant benefit to a wide range of patients, it carries risk of alloimmunization and other immune-mediated adverse reactions. Further characterization of the mechanisms regulating these outcomes can lead to new interventions to prevent alloimmunization and help to identify which platelet products are best suited to different patient populations.
Keywords: alloimmunization; immunomodulation; inflammation; platelet transfusion.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
References
-
- Tran JQ, Muench MO, Gaillard B, Darst O, Tomayko MM, Jackman RP: Polyinosinic: polycytidylic acid induced inflammation enhances while lipopolysaccharide diminishes alloimmunity to platelet transfusion in mice. Front Immunol 2023, 14:1281130. - PMC - PubMed
-
Found that inflammation can either suppress (LPS) or enhance (Poly(I:C)) the alloantibody response to platelet transfusion. Using MHC tetramers, phenotyped the allospecific B cell response and found that LPS treatment led to blocked activation and germinal cell differentiation of allospecific B cells, consistent with the reduced alloantibody response. Interestingly, the enhanced alloantibody response to platelet transfusion seen with poly(I:C) was associated with slight reductions in activation and germinal center responses within the allospecific B cell population and slight increases in marginal zone responses, suggestive of a extrafollicular contribution.
-
- Hendrickson JE, Chadwick TE, Roback JD, Hillyer CD, Zimring JC: Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood 2007, 110:2736–2743. - PubMed
-
- Hendrickson JE, Desmarets M, Deshpande SS, Chadwick TE, Hillyer CD, Roback JD, Zimring JC: Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 2006, 46:1526–1536. - PubMed
-
- Hendrickson JE, Roback JD, Hillyer CD, Easley KA, Zimring JC: Discrete Toll-like receptor agonists have differential effects on alloimmunization to transfused red blood cells. Transfusion 2008, 48:1869–1877. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
